Received Nov 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | MY9548 | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
sick; This is a spontaneous report received from a Consumer or other non HCP. A female patient in her 70's received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in 2024 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (DOSE NUMBER UNKNOWN), administration date: 2020, for COVID-19 immunization; Comirnaty (DOSE NUMBER UNKNOWN), administration date: 2021, for COVID-19 immunization; Comirnaty (DOSE NUMBER UNKNOWN), administration date: 2022, for COVID-19 immunization; Comirnaty (DOSE NUMBER UNKNOWN), administration date: 2023, for COVID-19 immunization. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sick". Additional Information: The patient had received the vaccine since 2020, that was Pfizer, 2021, 2022, 2023, 2024, none of them made her this sick. She was sick. She was in bed or stayed at home for a day and a half maybe, no big deal. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.